Viracta Therapeutics Stock Quote VIRX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.850339

Bid

0.81

Ask

0.8538

Volume

27,230

0.8101 Day's Range 0.90

0.43 52 Week Range 2.38

Market Cap

31.811M

Previous Close

0.821

Open

0.85

Last Trade

500

0.850339

Last Trade Time

11:20:44

Financial Volume

$ 23,524

VWAP

0.863889

Average Volume (3m)

118,510

Shares Outstanding

39,272,434

Dividend Yield

PE Ratio

-0.62

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-51.06M

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.viracta.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.82. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.43 to $ 2.38.

Viracta Therapeutics currently has 39,272,434 shares outstanding. The market capitalization of Viracta Therapeutics is $31.81 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.62.

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma

- Patients in the Nana-val (nanatinostat in combination with valganciclovir) treatment arm achieved clinically meaningful anti-tumor responses with an overall response rate of 50% and a complete...

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...

Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial

Accelerated pace of enrollment supports speed to market strategy Topline results from Stage 1 expected to be presented in the second quarter of 2024 followed by Stage 2 data in the third quarter...

Form 144 - Report of proposed sale of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.059661	-6.55615384615	0.91	0.91	0.76	58567	0.83539369	CS
4	-0.244661	-22.3434703196	1.095	1.31	0.67	138379	0.95416345	CS
12	0.230339	37.1514516129	0.62	1.31	0.54	118510	0.89341331	CS
26	0.160339	23.2375362319	0.69	1.31	0.43	140621	0.6855108	CS
52	-0.459661	-35.0886259542	1.31	2.38	0.43	155090	1.12873137	CS
156	-8.649661	-91.0490631579	9.5	13.08	0.43	187065	4.24099006	CS
260	-15.909661	-94.9263782816	16.76	18.24	0.43	198347	4.87249286	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AKLIAkili Inc	$ 0.46 (95.83%)	63.54M
WGSGeneDx Holdings Corporation	$ 17.665 (60.59%)	2.89M
GMMGlobal Mofy Metaverse Ltd	$ 1.47 (58.01%)	57.6M
AGBAAGBA Group Holding Ltd	$ 3.3601 (42.98%)	73.89M
CYCCCyclacel Pharmaceuticals Inc	$ 1.89 (38.97%)	17.3M
LICNLichen China Limited	$ 1.47 (-27.59%)	877.27k
BRNSBarinthus Biotherapeutics PLC	$ 1.88 (-27.41%)	102.98k
CETXCemtrex Inc	$ 1.33 (-25.28%)	152.37k
NRXPNRX Pharmaceuticals Inc	$ 2.7499 (-22.54%)	605.97k
NIVFNewGenIvf Group Ltd	$ 1.6303 (-20.08%)	1.46M
EGOXNext e GO NV	$ 0.03505 (26.99%)	76.4M
AGBAAGBA Group Holding Ltd	$ 3.3601 (42.98%)	73.89M
JAGXJaguar Health Inc	$ 0.2328 (11.92%)	68.12M
AKLIAkili Inc	$ 0.46 (95.83%)	63.54M
GMMGlobal Mofy Metaverse Ltd	$ 1.47 (58.01%)	57.6M